The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.

The FDA has approved expanded use of GE HealthCare’s PET imaging agent, Vizamyl, for improved detection and monitoring of Alzheimer’s disease. The updated label now allows Vizamyl to be used ...

FDA approves, expands 3 natural color additives after RFK Jr.'s plan to remove artificial food dyes RFK Jr. previously said he wants to phase out petroleum-based dyes.

The FDA announced it has approved the use of two color additives from natural sources in over a dozen foods and beverages while expanding the approval of another.According to a press release ...

The FDA expanded the approval of the SONU Band to include the treatment of patients aged 12 years and older with moderate to severe nasal congestion due to allergic or nonallergic rhinitis ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease remission and significantly improving symptoms like itch and disease ...

Historic achievement: FDA approval of Abeona Therapeutics' ZEVASKYN accelerates momentum and expands treatment options for the EB community.

FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis after positive trial data.

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased risk of the ...

(NEW YORK) — The U.S. Food and Drug Administration expanded its approval of Moderna’s respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased ...